In this issue:
Recommendations from the 10th ECIL
The management of cytomegalovirus
The management of COVID-19
TGA
New registrations
Medications under review
AusPAR for epcoritamab
PBAC recommendations
Upcoming PBAC agenda
Anticipated shortage of Bleomycin DBL
MSAC re-evaluates funding of axi-cel for follicular lymphoma
Status of regulatory approvals across the globe for medications under review in Australia
Recent drug approvals in the EU
New CAR T-cell accredited hospital in Brisbane
Inaugural ESMO Targeted Anticancer Therapies Asia Congress
FDA grants RMAT to investigational CD19-targeted CAR T-cell therapy for MCL
Conferences & Workshops
Please login below to download this issue (PDF)